CDKN2A and infection: However, an up-regulation of p16INK4a was identified in 8–20% of tumors with no evidence of HPV transforming infection [9,10], pointing the attention on the reliability of p16INK4a as a stand-alone test for the identification of HPV-driven OPSCC [11].